Whether trying to see more patients, retain more staff, expand the organization’s technology stack or bring more dollars in the door, it’s not uncommon for professionals to want to maximize their resources amidst a market influx. The post Want to Maximize Rev Cycle Efficiencies? Here are 3 Considerations appeared first on MedCity News.
This brief examines state policies related to prior authorization processes in Medicaid managed care and includes findings about how states approach prior authorization decision timeframes, electronic denial notices, and access to external medical reviews, all as of July 1, 2024.
In a statement today, CMS confirmed that Elon Musk and the Department of Government Efficiency (DOGE) has been given access to CMS payment systems: CMS has two senior Agency veterans – one focused on policy and one focused on operations – who are leading the collaboration with DOGE, including ensuring appropriate access to CMS systems…
The FDA decision for Travere Therapeutics’ Filspari also expands its addressable patient population. The full approval comes nearly a year after the Travere drug narrowly missed the main goal of its confirmatory study. The post Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas appeared first on MedCity News.
The FDA published more than 200 complete response letters, the first step in what it describes as part of its effort to modernize the agency and improve transparency. But there are some caveats to the release of the FDA correspondence. The post Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits appeared first…
How does patient quality of life impact caregiving burden? Often this is determined using caregiver surveys. However, a paper by Jiao et al. (2025) aims to use a data based approach to help estimate caregiver burden. They The authors use data from the 2010-2018 Health and Retirement Survey (HRS). HRS data was selected because there…
By focusing on integrating care teams, expanding community programs, and addressing SDoH through policy reform, we can create a healthcare system that serves all patients — especially those most in need. The post Patients Across the Country Deserve Better Access to Healthcare appeared first on MedCity News.
Radiotherapy, China’s biotech surge and AI’s role in drug discovery are notable topics that emerged from conversations on the ground floor. The post Three Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference appeared first on MedCity News.
Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to support potential expansion of the twice-daily pill to other immunological disorders. The post Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives appeared first on MedCity News.